http://www.cancernetwork.com/podcasts en-us 1996 - 2013 Perspectives in Oncology Cancer Network Interviews with experts on the top news and controversies in the field of oncology today. Interviews with experts on the top news and controversies in the field of oncology today. Cancer Network ian.ingram@ubm.com Cancer Network What oncology nurses need to know In this interview, Laura Zitella will be discussing challenges and considerations for management and prevention of infection in the oncology setting—in both patients with solid tumors and those with hematologic malignancies. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_zitella.mp3 Mon, 29 Apr 2013 19:00:00 GMT 11:37 oncology, cancer, nursing, ONS, ONS Congress, Oncology Nursing Society, infectious complications, complications Cancer Network A discussion with a credentialed advanced practice genetic nurse This interview covers standards for healthcare provider competency in offering comprehensive genetic services, and highlighting genetics/genomics resources for nurses. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_mahon.mp3 Thu, 25 Apr 2013 19:00:00 GMT 15:50 oncology, cancer, nursing, ONS, ONS Congress, genes, HER2, BRCA1, BRCA2, KRAS, BRAF, Oncology Nursing Society Cancer Network How it can be used to help patients In this interview, Tami Borneman, who is presenting a poster at the 38th Annual ONS Congress, will discuss spirituality: what it means, and how spiritual interventions can benefit patients with cancer. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_borneman.mp3 Wed, 24 Apr 2013 19:00:00 GMT 13:50 oncology, cancer, nursing, ONS, ONS Congress, Oncology Nursing Society Cancer Network Endpoints in oncology trials This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_moinpour.mp3 Fri, 12 Apr 2013 19:00:00 GMT 12:19 oncology, cancer, palliative care, clinical trials Cancer Network An update on lung cancer research In this interview, ahead of the AACR annual meeting, we speak with Dr. Julie Brahmer, of Johns Hopkins School of Medicine, who is giving a presentation on immunotherapy in lung cancer, and is one of the clinical investigators of the extensive phase I trial of the anti–PD-1 antibody nivolumab. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_brahmer.mp3 Fri, 5 Apr 2013 19:00:00 GMT 10:41 oncology, cancer, lung cancer Cancer Network Endpoints in oncology trials This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_reeve.mp3 Fri, 29 Mar 2013 19:00:00 GMT 13:25 oncology, cancer, QoL, quality of life, palliative care, clinical trials Cancer Network An update on new approvals and research As part of our coverage for the 30th Annual Miami Breast Cancer Conference, we bring you an interview with Dr. Mark Pegram, director of the breast cancer program at the Stanford Women’s Cancer Center and codirector of the molecular therapeutics program. Dr. Pegram will be discussing the potential for novel HER2 combination therapies at the conference. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_pegram.mp3 Wed, 6 Mar 2013 19:00:00 GMT 12:28 oncology, cancer, breast cancer, genetics, HER2 Cancer Network How do oncologists use social media? In this interview we discuss the dissemination of research results, clinical trials, and other oncology news using social media, as well as what type of media oncologists use, and how useful and relevant this type of information is for most oncologists. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_thompson.mp3 Wed, 27 Feb 2013 19:00:00 GMT 13:33 Twitter, Facebook, social media, oncology, oncologists Cancer Network A discussion of incidence and prevention In this interview we discuss HPV-associated cancers, which are on the rise, and the low vaccination coverage for HPV with Edgar Simard, PhD, MPH, senior epidemiologist of surveillance research, who studies the impact of prevention and screening on cancer incidence at the American Cancer Society. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_simard.mp3 Thu, 21 Feb 2013 19:00:00 GMT 13:56 oncology, cancer, HPV, cervical cancer, anal canal carcinoma, vaccines, gynecologic cancer Cancer Network Early treatment and active surveillance Ahead of the ASCO GU meeting, we spoke with two symposium committee members, Dr. Mack Roach, of the University of California, San Francisco, and Dr. Hans T. Chung, of the University of Toronto, about early treatment and surveillance of prostate cancer patients. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_ascogu.mp3 Wed, 13 Feb 2013 19:00:00 GMT 14:05 oncology, cancer, ASCO, ASCO GU, prostate cancer, active surveillance, PSA, overtreatment Cancer Network An update on the latest research In this interview we discuss the current management and latest treatments and agents in development for multiple myeloma with Dr. Kenneth Anderson of the Dana-Farber Cancer Institute. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_anderson.mp3 Thu, 31 Jan 2013 19:00:00 GMT 11:34 oncology, cancer, hematology, multiple myeloma, myeloma Cancer Network Discussion of the current research in GI cancers In this interview we discuss the latest treatments and research for gastrointestinal cancers with Dr. Cathy Eng, associate professor, department of gastrointestinal medical oncology, The University of Texas MD Anderson Cancer Center. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2013_eng.mp3 Thu, 24 Jan 2013 19:00:00 GMT 8:04 oncology, cancer, ASCO, ASCO GI, gastrointestinal cancer, colorectal cancer, GI cancer Cancer Network Discussion of the various TKIs and treatments for CML In this interview we discuss the latest chronic myeloid leukemia treatment and research with Dr. Michael Deininger, chief of the division of hematology at the University of Utah School of Medicine. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_deininger.mp3 Mon, 24 Dec 2012 19:00:00 GMT 15:36 CML, hematology, TKIs, chronic myeloid leukemia, leukemia, tyrosine kinase inhibitor Cancer Network Patients can have very different understandings of treatment goals In this interview we discuss what patients expect from their cancer treatment with Deborah Schrag, MD, MPH, associate professor at Harvard Medical School. Dr. Schrag recently published a study that aimed to discover how patients with advanced cancer understand the purpose of their chemotherapy treatment. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_schrag.mp3 Thu, 20 Dec 2012 19:00:00 GMT 10:11 patient care, oncology, chemotherapy, targeted therapy, palliative care, advanced cancer, metastatic Cancer Network ‘Remarkable synergy’ noted in early investigation of ritonavir and metformin Today we speak with Steven T. Rosen, MD, about a couple of the projects he and his group are working on, repurposing old drugs for the treatment of multiple myeloma, that will be presented this year at ASH. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_rosen.mp3 Mon, 10 Dec 2012 19:00:00 GMT 5:52 ASH 2012, myeloma, multiple myeloma, chemotherapy, repurposed drugs, hematology, American Society of Hematology Cancer Network Molecular assays for breast cancer in the clinic To kick off SABCS 2012, we discuss the use of molecular testing for the diagnosis and treatment of breast cancer patients in the clinical setting with Dr. Antonio Wolff of the Kimmel Cancer Center at Johns Hopkins University, one of the presenter's during the "Practical Use of Molecular Profiling" session at this year's symposium. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_wolff.mp3 Tue, 4 Dec 2012 19:00:00 GMT 13:59 breast cancer, molecular, SABCS, San Antonio, Breast Cancer Symposium Cancer Network Recent advances in the management of melanoma In this podcast we discuss the recent advances in the management and treatment of metastatic melanoma with Jeffrey Sosman, MD, medical oncologist and director of the Melanoma and Tumor Immunotherapy Program at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_sosman.mp3 Mon, 12 Nov 2012 19:00:00 GMT 16:47 melanoma, BRAF, inhibitor, vemurafenib, ipilimumab, skin cancer, Zelboraf, Yervoy Cancer Network Integrating palliative care into standard care In this podcast we discuss integrating palliative care into standard oncology care with Thomas J. Smith, director of palliative medicine at Sidney Kimmel Comprehensive Cancer Center. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_smith.mp3 Fri, 2 Nov 2012 19:00:00 GMT 14:02 palliative care, pain, patient care Cancer Network Discussion of the long-term cognitive effects of chemotherapy on patients In this podcast we discuss the long-term effects of chemotherapy on the cognitive function of cancer patients and the current status of research in this field. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_chemoeffects.mp3 Wed, 26 Sep 2012 19:00:00 GMT 14:47 chemo, chemotherapy, cognitive effects, chemo brain, patient care, long-term, side effects, chemo effects Cancer Network Important advances in the treatment of breast cancer We speak with Clifford Hudis, MD, Memorial Sloan-Kettering Cancer Center, about the recent advances in breast cancer treatment and the top news to come out of this year’s ASCO Breast Cancer Symposium. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_hudis.mp3 Thu, 20 Sep 2012 19:00:00 GMT 9:56 ASCO, breast cancer, breast cancer symposium, everolimus, Afinitor, BOLERO-2, axillary lymph node, surgery, HER2, ER-positive, androgen receptor, estrogen receptor Cancer Network Cancer care continues to rise The cost of cancer treatment has at least doubled since 1987 and there does not appear to be any hint that cancer care costs will decline. In this podcast we discuss the reasons for the increase in costs, as well as the ethics of cancer care cost containment. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_caplan.mp3 Thu, 23 Aug 2012 19:00:00 GMT 12:00 oncology, cancer, health care, research, cost-effectiveness, ethics, comparitive effectiveness, health insurance, cancer care Cancer Network A novel approach to health economics research Chemotherapy regimens that 10 years ago cost $30,000 have now increased ten-fold. Could a new research facility help make cancer care affordable again? We speak with Dr. Scott Ramsey to find out about this new facility, the Institute for Cancer Outcomes Research and Evaluation, which aims to do just that. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_ramsey.mp3 Wed, 22 Aug 2012 19:00:00 GMT 9:06 oncology, cancer, health care, research, cost-effectiveness, comparitive effectiveness, health insurance, cancer care Cancer Network PSA screening; treatment or observation for early disease We speak with Dr. Ian Thompson about hot button issues in prostate cancer today: which patitents should be screened, which should be biopsied, and whether to treat or observe early disease. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_thompson.mp3 Tue, 14 Aug 2012 19:00:00 GMT 15:07 oncology, cancer, prostate cancer, PSA, surgery, observation, treatment Cancer Network Implications for practicing oncologists We speak with two practicing oncologists, Dr. Paul R. Helft and Dr. David Eagle, about how the recent Supreme Court decision to uphold the Affordable Care Act will affect oncology practices and cancer patients. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_eagle_helft.mp3 Thu, 19 Jul 2012 19:00:00 GMT 20:18 oncology, cancer, healthcare, supreme court, affordable care act, health care Preventing metastases should be endpoint Cancer Network We speak with Patricia S. Steeg, PhD, who has recently written a perspective in the journal Nature calling for a shift in both the types of drugs that are developed for breast cancer and in the way clinical trials are designed and executed. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_steeg.mp3 Thu, 12 Jul 2012 19:00:00 GMT 15:46 oncology, cancer, breast cancer, health, clinical trials, metastatic New targeted therapies Cancer Network We speak with Dr. Sara Hurvitz, director of the breast cancer program at the University of California in Los Angeles. Dr. Hurvitz is actively involved in translational phase I/II breast cancer clinical trials as well as in research to better define distinct types of breast tumors to better design novel targeted therapies. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_hurvitz.mp3 Wed, 11 Jul 2012 19:00:00 GMT 12:50 oncology, cancer, novel agents, new therapies, T-DM1, trastuzumab, breast cancer, health, ASCO, clinical trials, metastatic Understanding the mutations is just one step Cancer Network We discuss the diagnosis and treatment of metastatic pancreatic cancer with Dr. Diane Simeone, who is involved in both pancreatic cancer clinical trials as well as research to better characterize important pancreatic cancer pathways and identify biomarkers for the disease. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_pancreatic.mp3 Thu, 5 Jul 2012 19:00:00 GMT 12:55 oncology, cancer, pancreatic cancer, pancreas, biomarkers, treatment, management, oncogene, gene mutations, neuroendocrine tumors Latest trial results and emerging therapies Cancer Network We present an exclusive interview with Dr. Kimberly Blackwell, Duke Cancer Institute, who discusses some of the most important information to come out of this year’s meeting, including the EMILIA study, and talks about the future of breast cancer research. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/ASCO12_blackwell.mp3 Thu, 21 Jun 2012 19:00:00 GMT 13:55 oncology, cancer, novel agents, new therapies, T-DM1, trastuzumab, breast cancer, health, ASCO, clinical trials, metastatic New, exciting era for research and treatment of CLL Cancer Network We speak with Dr. Hagop Kantarjian of the M.D. Anderson Cancer Center, who shares his impressions of some of the highlights of this year’s ASCO meeting with regard to hematologic malignancies. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/ASCO12_kantarjian.mp3 Mon, 18 Jun 2012 19:00:00 GMT 13:06 hematology, cancer, leukemia, CLL, chronic, myeloid, lymphocytic, CML, tyrosine kinase inhibitors, TKIs, ALL, ASCO, clinical trials Latest trial results and emerging therapies Cancer Network We present an exclusive interview with Joel W. Neal, MD, PhD, who discusses some of the most important information to come out of this year’s meeting and talks about the future of lung cancer research. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/ASCO12_neal.mp3 Fri, 15 Jun 2012 19:00:00 GMT 10:22 lung cancer, oncology, screening, non-small cell, ASCO, PD-1, clinical trials Latest treatments and emerging therapies Cancer Network In this exclusive interview, Michael B. Atkins, MD, director of the Georgetown Lombardi Comprehensive Cancer Center, discusses some of the most important melanoma research to come out of this year’s ASCO meeting and talks about the future of melanoma therapies. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/ASCO_atkins.mp3 Mon, 11 Jun 2012 19:00:00 GMT 16:33 melanoma, skin cancer, oncology, programmed cell death 1, PD1, ASCO, BRAF, dabrafenib, vemurafenib, ipilimumab, immunotherapy, targeted therapy Updated guidelines Cancer Network The debate over screening for lung cancer continues. While there have been many advances in treatment for late-stage disease, screening and prevention are likely the most cost effective and best approaches to preventing lung cancer deaths. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_lung_screening.mp3 Fri, 25 May 2012 19:00:00 GMT 17:16 lung cancer, oncology, screening, non-small cell, small-cell, CT scans, PET scans, cost effectiveness, overdiagnosis, overtreatment Current options and novel therapies Cancer Network In this interview we speak with two prostate cancer experts, Andrew J. Armstrong and Tomasz M. Beer, both of whom are actively involved in the research and clinical trials of novel agents, on the topic of newly available and upcoming treatment options for patients with castration-resistant prostate cancer. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012-04-prostate.mp3 Thu, 26 Apr 2012 19:00:00 GMT 21:14 prostate cancer, oncology, abiraterone, overall survival, castration-resistant, PREVAIL, immunotherapy New approach prevents invasiveness Cancer Network Ductal carcinoma in situ (DCIS) is the most commonly diagnosed, noninvasive type of breast cancer in women. In this interview, Dr. Lance Liotta and Professor Virginia Espina, whose laboratory has been one the first to successfully culture living DCIS cells, discuss novel ways to stop breast cancer before it becomes invasive and malignant. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012-liotta.mp3 Fri, 20 Apr 2012 19:00:00 GMT 10:00 DCIS, oncology, breast cancer, prevention, ductal carcinoma, PINC trial, chloroquine New therapies Cancer Network Triple-negative breast cancer is aggressive, has a high rate of metastases, and carries a poor prognosis. Dr. Joyce O’Shaughnessy, who will be presenting at the Miami Breast Cancer Conference, discusses an overview of new therapies for triple-negative breast cancer. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/mbcc2012-oshaughnessy.mp3 Mon, 12 Mar 2012 19:00:00 GMT 10:41 oncology, breast cancer, triple-negative, MBCC, miami breast cancer conference, bevacizumab, carboplatin, ixabepilone, TRAIL inhibitor, capecitabine Challenges of developing therapeutics Cancer Network We interview two prominent ovarian cancer researchers from both sides of the Atlantic, Dr. Michael Birrer and Dr. Jonathan Ledermann, on the role of PARP inhibitors and the challenges of developing ovarian cancer therapies. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2012_march_ovarian_podcast.mp3 Wed, 7 Mar 2012 19:00:00 GMT 15:03 oncology, ovarian cancer, PARP inhibitors, ASCO, BRCA, bevacizumab Cost considerations and long-term benefit benchmarks Cancer Network In this interview, Christopher-Paul Milne and Kenneth Kaitin, Tufts Center for the Study of Drug Development. discuss the current challenges of the US Food and Drug Administration review process as it relates to oncology therapeutics and upcoming changes to the Prescription Drug User Fee Act. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/fda_podcast.mp3 Wed, 22 Feb 2012 19:00:00 GMT 11:33 oncology, FDA, review process, bevacizumab, progression-free survival, overall survival, clinical trials, endpoints Study shows drug increases complete response Cancer Network Dr. Gunter von Minckwitz discusses the recent paper he authored that showed that bevacizumab in addition to neoadjuvant chemotherapy significantly increased the rate of pathological complete response in patients with early stage HER2-negative breast cancer. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/vonminckwitz-podcast.mp3 Mon, 13 Feb 2012 19:00:00 GMT 10:45 oncology, breast cancer, triple-negative, bevacizumab, NEJM, new england journal, neoadjuvant, surgery Is a noninvasive, affordable screening tool close? Cancer Network In this interview, Dr. David Ahlquist, gastroenterologist and professor of medicine at the Mayo Clinic in Rochester in Minnesota, discusses early detection methods of colorectal cancer, touching on sigmoidoscopy, colonoscopies, fecal blood testing, and in particular, stool DNA screening. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/ahlquist-podcast.mp3 Thu, 9 Feb 2012 19:00:00 GMT 8:42 oncology, colorectal cancer, colon cancer, screening, colonoscopy, fecal blood testing, cancer testing, prevention, sigmoidoscopy, polyps Selective inhibitors of the VEGF pathway, and novel targets Cancer Network We speak with Dr. Michael Atkins, who has extensive clinical experience in kidney cancer and development of various new treatments, and is presenting this weekend during the renal cancer translational science session at the American Society of Clinical Oncology 2012 Genitourinary Cancers Symposium. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/asco2012_gu_atkins.mp3 Fri, 3 Feb 2012 19:00:00 GMT 11:58 oncology, kidney cancer, urothelial carcinoma, renal cell carcinoma, axitinib, immunotherapy, kidney tumors, SPORE, ASCO GU, genitourinary cancers Are tailored treatments necessary? Cancer Network Andrew Evens, DO, MSc, deputy director for clinical and translational research and medical director of the Clinical Research Office at the UMass Memorial Health Care Cancer Center of Excellence, talks about his research on lymphoma during pregnancy. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/sabcs2011_evens.mp3 Sun, 11 Dec 2011 19:00:00 GMT 16:51 hematology, cancer, lymphoma, Hodgkin, ASH, pregnancy, chemotherapy, non-Hodgkin, B-cell, T-cell CLEOPATRA trial and more Cancer Network We interview Kent Osborne, the moderator of the year in review session. He has been involved with the meeting since its beginning. The international San Antonio Breast Cancer Symposium is unique as it facilitates the interaction of both basic and science researchers and clinicians to combine the efforts of laboratory research and clinical research for better treatment and patient care. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/sabcs2011_osborne.mp3 Fri, 2 Dec 2011 19:00:00 GMT 15:20 oncology, breast cancer, San Antonio, SABCS, HER2-positive, trastuzumab, CLEOPATRA, ALTTO, lapatinib, Herceptin Decision-making tools Cancer Network We speak with Dr. Joseph Sparano, professor of medicine and women’s health at the Albert Einstein School of Medicine and associate chairman of the department of oncology at Montefiore Medical Center in New York, about the session he will chair at the ASCO Breast Cancer Symposium. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/asco2011-sparano.mp3 Tue, 30 Aug 2011 19:00:00 GMT 13:46 oncology, breast cancer, ASCO, breast cancer symposium, MINDACT, ER-positive, Oncotype DX, TAILORx, HER2-negative, MammaPrint assay, tamoxifen Session preview Cancer Network Dr. Susan O’Brien was one of the presenters at the ASCO 2011 session on therapies for chronic lymphocytic leukemia, in this podcast she gives some highlights of the session and insights into her own work. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/asco2011-obrien.mp3 Thu, 2 Jun 2011 19:00:00 GMT 13:10 hematology, ASCO, leukemia, CLL, targeted therapy, B-cell, molecular pathways, P13K kinase, CAL-101, PCI-32765 Session preview Cancer Network We talk with Dr. David Mankoff, professor of radiology, medicine, and bioengineering in the department of radiology at the University of Washington in Seattle. Dr. Mankoff will be one of the co-chairs at the upcoming ASCO session on molecular imaging in cancer clinical trials, and he gives us a preview of what some of the highlights of the session are likely to be, as well as some insights into his own work. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/asco2011-mankoff.mp3 Thu, 2 Jun 2011 18:00:00 GMT 10:12 breast cancer, detection, imaging, screening, controversies, PET, MRI, FDG-PET, ACRIN, ASCO Targeted therapies Cancer Network The combination of biomarkers and molecular pathology will aid oncologists in developing targeted treatments for breast cancer, according to Samuel Aparicio, MD, PhD, who will be delivering a presentation on recognizing breast cancer heterogeneity in targeted treatment at the Miami Breast Cancer Conference this week. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/mbcc2011-aparicio.mp3 Wed, 9 Mar 2011 19:00:00 GMT 1:31 oncology, breast cancer, Miami breast cancer conference, biomarkers, targeted therapy Are PARP inhibitors ready for prime time? Cancer Network The early promise of treating triple-negative and basal-cell breast cancers with poly (ADP-ribose) polymerase (PARP) inhibitors is yet to be realized, according to Lisa A. Carey, MD, who will be delivering a presentation on treatment options for these patients at the Miami Breast Cancer Conference this week. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/mbcc2011-carey.mp3 Wed, 9 Mar 2011 18:00:00 GMT 7:51 oncology, breast cancer, Miami breast cancer conference, triple-negative breast, PARP, basal-cell, biomarkers, targeted therapy Still work to be done Cancer Network The discovery of human epidermal growth factor receptor 2 (HER2)-positive breast cancer subtypes is not yet complete, according to Mark D. Pegram, MD, who will be delivering a presentation on the different clinical outcomes of these subtypes at the Miami Breast Cancer Conference this week. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/mbcc2011-pegram.mp3 Tue, 8 Mar 2011 19:00:00 GMT 3:33 oncology, breast cancer, Miami breast cancer conference, HER2-negative, mutations, genes, gene-expression, targeted therapy Not ready for full-time use Cancer Network Are genomic profiles refined enough that they should be used routinely to determine which breast cancer patients should receive adjuvant therapy? According to J. Michael Dixon, MD, who will be presenting the contra argument to this question in a debate at the Miami Breast Cancer Conference this week, the answer is: Not yet. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/mbcc2011-dixon.mp3 Tue, 8 Mar 2011 18:00:00 GMT 6:27 oncology, breast cancer, Miami breast cancer conference, gene profiles, Oncotype DX, HER2 Pros and cons Cancer Network We speak with expert Emily Conant, MD, who says it’s very important to carefully analyze the data and weigh the pros and cons and the risk to benefits that exist within any study. Naturally, because mammography is such a widely used screening tool, it gets quite a bit of scrutiny. But it is all about the data, how it’s sliced and diced. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/Conant-podcast.mp3 Wed, 6 Oct 2010 19:00:00 GMT 15:09 oncology, breast cancer, screening, mammography, surgery, MRI, BRCA, symptoms Buyer beware Cancer Network Clinicians often cite enhanced quality care, patient safety, and increased efficiencies as rationale for implementing electronic medical records. Those are strong reasons for interest in medical software. However, in a climate where reimbursements are falling, the cost and difficulty of EMRs can increasingly seem to be a barrier. We speak with nationally recognized healthcare specialist Marty Neltner to find out. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2010-neltner.mp3 Mon, 12 Jul 2010 19:00:00 GMT 10:24 oncology, medical record, EMR, EHR, health record, electronic, coding Novel targets and enhanced donor transplantation Cancer Network We speak with Dr. Samuel Silver who elucidates the current trends and therapies for treating various blood cancers. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2010-silver.mp3 Wed, 9 Jun 2010 19:00:00 GMT 6:35 hematology, leukemia, lymphoma, transplantation, targeted therapy Novel targets and enhanced donor transplantation Cancer Network We speak with Dr. Samuel Silver who elucidates the current trends and therapies for treating various blood cancers. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2010-silver.mp3 Wed, 9 Jun 2010 19:00:00 GMT 6:35 hematology, leukemia, lymphoma, transplantation, targeted therapy Future trends Cancer Network In this exclusive podcast, nationally regarded healthcare specialist, Marty Neltner, talks about how given the current atmosphere in today's challenging healthcare market, community oncology practices need to be especially alert to future trends, one of which is value over volume. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2010-neltner-value.mp3 Tue, 8 Jun 2010 19:00:00 GMT 9:30 oncology, healthcare, health care, community oncology, value, trends Targeted therapies Cancer Network Listen to internationally regarded oncologist and clinical investigator, Robert J. Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center, discuss the past, present, and future trends in renal cell carcinoma. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2010-motzer.mp3 Tue, 8 Jun 2010 18:00:00 GMT 9:28 oncology, cancer, renal cell carcinoma, RCC, antiangiogenesis, metastatic, chemotherapy resistance New generation shows promise Cancer Network In this exclusive ASCO podcast, Andrew J. Armstrong, MD, ScM, assistant professor of medicine and surgery at Duke Comprehensive Cancer Center, addresses the vexing clinical issue of chemotherapy’s limited effectiveness in advanced renal cell carcinoma. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2010-armstrong.mp3 Mon, 7 Jun 2010 19:00:00 GMT 5:27 oncology, cancer, renal cell carcinoma, RCC, antiangiogenesis, metastatic, chemotherapy resistance A misnomer? Cancer Network Dr. Debu Tripathy, co-course director for the 27th Annual Miami Breast Cancer Conference sheds light on his presentation, The Role of Maintenance Therapy for Metastatic Breast Cancer, truly a complicated and controversial topic. http://imaging.ubmmedica.com/all/editorial/cancernetwork/podcasts/2010-tripathy.mp3 Fri, 26 Feb 2010 19:00:00 GMT 7:19 oncology, cancer, MBCC, Miami breast cancer conference, breast cancer, metastatic, maintenance therapy, Avastin, hormonal therapy, chemotherapy, bevacizumab